The contribution of active inflammatory pathology and local complement activation in the thalamus to progressive multiple sclerosis outcome

被引：0
|
作者：
Cooze, B. [1 ]
Dickerson, M. [1 ]
Loganathan, R. [1 ]
Grounds, E. [1 ]
Watkins, L. M. [1 ]
Bevan, R. J. [2 ]
Magliozzi, R. [3 ]
Reynolds, R. [4 ]
Neal, J. W. [1 ]
Howell, O. W. [1 ]
机构：
[1] Swansea Univ, Sch Med, Swansea, W Glam, Wales
[2] Cardiff Univ, UK Dementia Res Inst, Cardiff, Wales
[3] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy
[4] Imperial Coll London, Dept Med, London, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
132
引用
收藏
页码：80 / 81
页数：2
相关论文
共 50 条
  • [41] LOCAL COMPLEMENT ACTIVATION IN INFLAMMATORY BOWEL-DISEASE
    HALSTENSEN, TS
    BRANDTZAEG, P
    IMMUNOLOGIC RESEARCH, 1991, 10 (3-4) : 485 - 492
  • [42] Cerebellar volume as imaging outcome in progressive multiple sclerosis
    Inglese, Matilde
    Petracca, Maria
    Mormina, Enricomaria
    Achiron, Anat
    Straus-Farber, Rebecca
    Miron, Shmuel
    Fabian, Michelle
    Krieger, Stephen
    Miller, Aaron
    Lublin, Fred
    Sormani, Maria Pia
    PLOS ONE, 2017, 12 (04):
  • [43] Cerebrospinal Fluid Determinants of Outcome in Progressive Multiple Sclerosis
    Tang, Junger
    Crusan, Daniel
    Tutuncu, Melih
    Abou Zeid, Nuhad
    Kale, Nilufer
    Atkinson, Elizabeth
    Kantarci, Orhun
    NEUROLOGY, 2011, 76 (09) : A65 - A66
  • [44] Imaging outcome measures for progressive multiple sclerosis trials
    Moccia, Marcello
    de Stefano, Nicola
    Barkhof, Frederik
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (12) : 1614 - 1626
  • [45] Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis
    Metz, I.
    Radue, E. -W.
    Oterino, A.
    Kuempfel, T.
    Wiendl, H.
    Schippling, S.
    Kuhle, J.
    Sahraian, M. A.
    Gray, F.
    Jakl, V.
    Haeusler, D.
    Brueck, W.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S17 - S18
  • [46] Identifying active secondary progressive multiple sclerosis (SPMS)
    Martin, Sarah-Jane
    Raufdeen, Fasna
    Marriott, James
    Oh, Jiwon
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 171 - 172
  • [47] Treatment of active secondary progressive multiple sclerosis with treosulfan
    H. Wiendl
    B. C. Kieseier
    R. Weissert
    H. A. Mylius
    U. Pichlmeier
    H.-P. Hartung
    A. Melms
    W. Kuker
    M. Weller
    Journal of Neurology, 2007, 254 : 884 - 889
  • [48] How common is active inflammation in progressive multiple sclerosis?
    Robert J. Fox
    Nature Reviews Neurology, 2021, 17 : 463 - 464
  • [49] Treatment of active secondary progressive multiple sclerosis with treosulfan
    Wiendl, Heinz
    Kieseier, Bernd C.
    Weissert, Robert
    Mylius, Heidrun A.
    Pichlmeier, Uwe
    Hartung, Hans-Peter
    Melms, Arthur
    Kuker, Wilhelm
    Weller, Michael
    JOURNAL OF NEUROLOGY, 2007, 254 (07) : 884 - 889
  • [50] How common is active inflammation in progressive multiple sclerosis?
    Fox, Robert J.
    NATURE REVIEWS NEUROLOGY, 2021, 17 (08) : 463 - 464
12345